BlackRock Institutional Trust Company, N.A. - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 66 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2016$1,396,000
+20.8%
303,516
+11.3%
0.00%
Q3 2016$1,156,000
+84.1%
272,705
+4.2%
0.00%
Q2 2016$628,000
-32.2%
261,678
+32.8%
0.00%
Q1 2016$926,000
+18.9%
197,074
-0.5%
0.00%
Q4 2015$779,000
+10.3%
198,103
+8.6%
0.00%
Q3 2015$706,000
+108.9%
182,377
+148.0%
0.00%
Q2 2015$338,000
+412.1%
73,531
+648.1%
0.00%
Q1 2015$66,0009,8290.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 5,292,156$7,144,0000.82%
Northeast Financial Consultants Inc 732,265$988,0000.30%
Family Management Corp 10,424$14,0000.01%
LMR Partners LLP 81,550$110,0000.01%
ELEMENT CAPITAL MANAGEMENT LLC 148,528$201,0000.01%
Poehling Capital Management, INC. 3,302$4,0000.00%
Paloma Partners Management Co 143,800$194,0000.00%
Founders Capital Management 3,000$4,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 186,254$251,0000.00%
FNY Investment Advisers, LLC 4,230$5,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders